Rang	Name	Position
1	Dr. Arie S. Belldegrun F.A.C.S., M.D.	Co-Founder & Executive Chairman
2	Dr. Zachary J. Roberts M.D., Ph.D.	President, CEO & Director
3	Mr. Joshua A. Kazam	Co-Founder & Director
4	Dr. David D. Chang M.D., Ph.D.	Co-Founder & Director
5	Mr. Geoffrey M. Parker	Executive VP & CFO
6	Mr. Benjamin M. Beneski	Senior VP & Chief Technical Officer
7	Mr. Earl M. Douglas Esq.	Senior VP, General Counsel, Compliance Officer & Corporate Secretary
8	Ms. Susan R. Lundeen	Chief People Officer
9	Ms. Christine Cassiano	Executive VP, Chief Corporate Affairs & Brand Strategy Officer
10	Ms. Annie Yoshiyama	SVP & Corporate Controller

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Pfizer Inc	6,38%	43,64 Mio. USD
2	BlackRock Inc	5,53%	37,82 Mio. USD
3	TPG GP A, LLC	5,42%	37,07 Mio. USD
4	Sio Capital Management, LLC	3,86%	26,39 Mio. USD
5	PRIMECAP Management Company	3,80%	26,00 Mio. USD
6	State Street Corp	2,51%	17,15 Mio. USD
7	Vanguard Capital Management, LLC	2,00%	13,71 Mio. USD
8	Citadel Advisors Llc	1,97%	13,46 Mio. USD
9	T. Rowe Price Associates, Inc.	1,56%	10,66 Mio. USD
10	Two Sigma Investments LLC	1,56%	10,65 Mio. USD
11	GordonMD Global Investments LP	1,53%	10,49 Mio. USD
12	Patient Square Capital LP	1,46%	10,00 Mio. USD
13	Aberdeen Group PLC	1,45%	9,91 Mio. USD
14	Millennium Management LLC	1,40%	9,60 Mio. USD
15	D. E. Shaw & Co LP	1,36%	9,33 Mio. USD
16	Geode Capital Management, LLC	1,19%	8,17 Mio. USD
17	Frazier Life Sciences Management, L.P.	1,10%	7,52 Mio. USD
18	Woodline Partners LP	1,01%	6,94 Mio. USD
19	Marshall Wace Asset Management Ltd	1,00%	6,83 Mio. USD
20	Dimensional Fund Advisors, Inc.	0,94%	6,42 Mio. USD